| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor activity | 5.27e-16 | 60 | 34 | 9 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 6.18e-16 | 61 | 34 | 9 | GO:0098531 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 2.44e-10 | 7 | 34 | 4 | GO:0044323 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 5.46e-10 | 25 | 34 | 5 | GO:0003707 | |
| GeneOntologyMolecularFunction | zinc ion binding | NR4A2 ZCCHC4 NR4A3 NR2C1 RARA RARB HNF4G ENPP1 RXRA RXRB RXRG OTUD7B OTUD7A | 9.89e-10 | 891 | 34 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | NR4A2 ZCCHC4 NR4A3 NR2C1 RARA RARB HNF4G ENPP1 RXRA RXRB RXRG OTUD7B OTUD7A | 3.18e-08 | 1189 | 34 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.20e-07 | 27 | 34 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.25e-06 | 55 | 34 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.29e-05 | 85 | 34 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.52e-05 | 187 | 34 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 8.25e-05 | 1412 | 34 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.05e-04 | 54 | 34 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.74e-04 | 1244 | 34 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.05e-04 | 1271 | 34 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.33e-04 | 753 | 34 | 7 | GO:0008134 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.33e-04 | 16 | 34 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.01e-04 | 582 | 34 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 4.23e-04 | 18 | 34 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 5.25e-04 | 20 | 34 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 5.70e-04 | 1459 | 34 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.79e-04 | 21 | 34 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 6.55e-04 | 417 | 34 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 6.96e-04 | 23 | 34 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 8.91e-04 | 26 | 34 | 2 | GO:0070530 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.03e-03 | 28 | 34 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.53e-03 | 34 | 34 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.72e-03 | 140 | 34 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.42e-03 | 560 | 34 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.53e-03 | 566 | 34 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.84e-03 | 167 | 34 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.02e-03 | 48 | 34 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.15e-03 | 49 | 34 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 4.53e-03 | 59 | 34 | 2 | GO:0031593 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.12e-03 | 206 | 34 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | coreceptor activity | 6.68e-03 | 72 | 34 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | calcium ion binding | 8.27e-03 | 749 | 34 | 5 | GO:0005509 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 3.35e-11 | 38 | 34 | 6 | GO:0048384 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | NR4A2 NR4A3 NR2C1 VPS18 KMT2D RARA RARB HNF4G RXRA RXRB RXRG | 3.71e-11 | 416 | 34 | 11 | GO:0030522 |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.59e-10 | 244 | 34 | 9 | GO:0009755 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.07e-09 | 202 | 34 | 8 | GO:0141193 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 5.36e-09 | 155 | 34 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | NR4A2 NR4A3 NR2C1 VPS18 KMT2D RARA RARB ENPP1 RXRA RXRB RXRG | 1.32e-08 | 727 | 34 | 11 | GO:0032870 |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 2.34e-08 | 19 | 34 | 4 | GO:0055012 | |
| GeneOntologyBiologicalProcess | response to hormone | NR4A2 NR4A3 NR2C1 VPS18 KMT2D RARA RARB ATP2A1 ENPP1 RXRA RXRB RXRG | 5.06e-08 | 1042 | 34 | 12 | GO:0009725 |
| GeneOntologyBiologicalProcess | regulation of myelination | 8.04e-08 | 67 | 34 | 5 | GO:0031641 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.06e-07 | 239 | 34 | 7 | GO:0071383 | |
| GeneOntologyBiologicalProcess | cellular response to lipid | 2.21e-07 | 748 | 34 | 10 | GO:0071396 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | NR4A3 NR2C1 VPS18 KMT2D RARA GRM2 ENPP1 RXRA RXRB RXRG WNT8B | 5.37e-07 | 1048 | 34 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | myelination | 9.83e-07 | 206 | 34 | 6 | GO:0042552 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 1.07e-06 | 209 | 34 | 6 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 1.07e-06 | 209 | 34 | 6 | GO:0007272 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.57e-06 | 52 | 34 | 4 | GO:0042789 | |
| GeneOntologyBiologicalProcess | embryo development | NR4A3 CELSR1 KMT2D RARA RARB TECTA KDF1 ENPP1 RXRA RXRB WNT8B OTUD7B | 1.62e-06 | 1437 | 34 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | mRNA transcription | 2.28e-06 | 57 | 34 | 4 | GO:0009299 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 2.30e-06 | 131 | 34 | 5 | GO:0032526 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.43e-06 | 381 | 34 | 7 | GO:0048545 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 8.21e-06 | 870 | 34 | 9 | GO:0030855 | |
| GeneOntologyBiologicalProcess | response to lipid | 8.89e-06 | 1126 | 34 | 10 | GO:0033993 | |
| GeneOntologyBiologicalProcess | epithelium development | FNDC3B FNDC3A CELSR1 RARA RARB TECTA KDF1 TNMD PTGS1 ENPP1 RXRA | 1.43e-05 | 1469 | 34 | 11 | GO:0060429 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.60e-05 | 713 | 34 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | response to vitamin | 2.16e-05 | 100 | 34 | 4 | GO:0033273 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 3.94e-05 | 6 | 34 | 2 | GO:0071376 | |
| GeneOntologyBiologicalProcess | positive regulation of vitamin D receptor signaling pathway | 3.94e-05 | 6 | 34 | 2 | GO:0070564 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 3.94e-05 | 6 | 34 | 2 | GO:0043435 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 4.87e-05 | 605 | 34 | 7 | GO:0071407 | |
| GeneOntologyBiologicalProcess | bone growth | 5.54e-05 | 45 | 34 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | organ growth | 5.87e-05 | 256 | 34 | 5 | GO:0035265 | |
| GeneOntologyBiologicalProcess | tube development | 5.92e-05 | 1402 | 34 | 10 | GO:0035295 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 5.98e-05 | 625 | 34 | 7 | GO:0051960 | |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 7.34e-05 | 8 | 34 | 2 | GO:0071947 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 7.42e-05 | 269 | 34 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | developmental growth | 9.15e-05 | 911 | 34 | 8 | GO:0048589 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.16e-04 | 154 | 34 | 4 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D receptor signaling pathway | 1.18e-04 | 10 | 34 | 2 | GO:0070562 | |
| GeneOntologyBiologicalProcess | protein K11-linked deubiquitination | 1.18e-04 | 10 | 34 | 2 | GO:0035871 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.58e-04 | 730 | 34 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.58e-04 | 1269 | 34 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | vitamin D receptor signaling pathway | 1.72e-04 | 12 | 34 | 2 | GO:0070561 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 1.76e-04 | 516 | 34 | 6 | GO:0016055 | |
| GeneOntologyBiologicalProcess | heart development | 1.97e-04 | 757 | 34 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 1.99e-04 | 177 | 34 | 4 | GO:0055007 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell migration | 2.08e-04 | 70 | 34 | 3 | GO:1904738 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.31e-04 | 343 | 34 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 2.35e-04 | 73 | 34 | 3 | GO:0071300 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.49e-04 | 1053 | 34 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.57e-04 | 351 | 34 | 5 | GO:0048562 | |
| GeneOntologyBiologicalProcess | response to nutrient | 2.71e-04 | 192 | 34 | 4 | GO:0007584 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.77e-04 | 561 | 34 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 2.97e-04 | 79 | 34 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 3.08e-04 | 365 | 34 | 5 | GO:0002263 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 3.14e-04 | 1390 | 34 | 9 | GO:0045944 | |
| GeneOntologyBiologicalProcess | adult behavior | 3.35e-04 | 203 | 34 | 4 | GO:0030534 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 3.89e-04 | 1125 | 34 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | circulatory system development | 4.12e-04 | 1442 | 34 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 4.29e-04 | 1450 | 34 | 9 | GO:1901701 | |
| GeneOntologyBiologicalProcess | regulation of bone mineralization | 4.50e-04 | 91 | 34 | 3 | GO:0030500 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 4.50e-04 | 91 | 34 | 3 | GO:0002067 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 4.62e-04 | 221 | 34 | 4 | GO:0035051 | |
| GeneOntologyBiologicalProcess | limb development | 4.86e-04 | 224 | 34 | 4 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.86e-04 | 224 | 34 | 4 | GO:0048736 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 5.79e-04 | 1194 | 34 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 6.53e-04 | 23 | 34 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | growth | 7.24e-04 | 1235 | 34 | 8 | GO:0040007 | |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 8.68e-04 | 114 | 34 | 3 | GO:0070167 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 9.02e-04 | 27 | 34 | 2 | GO:0010875 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 1.04e-03 | 29 | 34 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.11e-03 | 124 | 34 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 1.19e-03 | 31 | 34 | 2 | GO:0071295 | |
| GeneOntologyBiologicalProcess | protein K48-linked deubiquitination | 1.19e-03 | 31 | 34 | 2 | GO:0071108 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper cell differentiation | 1.19e-03 | 31 | 34 | 2 | GO:0045624 | |
| GeneOntologyBiologicalProcess | ear development | 1.19e-03 | 285 | 34 | 4 | GO:0043583 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.24e-03 | 129 | 34 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell proliferation | 1.27e-03 | 32 | 34 | 2 | GO:2000647 | |
| GeneOntologyBiologicalProcess | protein K63-linked deubiquitination | 1.27e-03 | 32 | 34 | 2 | GO:0070536 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.28e-03 | 750 | 34 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 1.29e-03 | 291 | 34 | 4 | GO:0045444 | |
| GeneOntologyBiologicalProcess | Sertoli cell differentiation | 1.35e-03 | 33 | 34 | 2 | GO:0060008 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 1.60e-03 | 36 | 34 | 2 | GO:1904754 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 1.60e-03 | 36 | 34 | 2 | GO:0061037 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 1.60e-03 | 36 | 34 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 1.61e-03 | 1077 | 34 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.63e-03 | 1399 | 34 | 8 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.73e-03 | 1413 | 34 | 8 | GO:1902679 | |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 1.74e-03 | 145 | 34 | 3 | GO:0014909 | |
| GeneOntologyBiologicalProcess | response to vitamin D | 1.79e-03 | 38 | 34 | 2 | GO:0033280 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 1.81e-03 | 147 | 34 | 3 | GO:0030278 | |
| GeneOntologyBiologicalProcess | bone mineralization | 1.88e-03 | 149 | 34 | 3 | GO:0030282 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 1.88e-03 | 39 | 34 | 2 | GO:0003416 | |
| GeneOntologyCellularComponent | transcription regulator complex | 3.93e-06 | 596 | 34 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 7.35e-05 | 272 | 34 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | chromatin | 4.53e-04 | 1480 | 34 | 9 | GO:0000785 | |
| MousePheno | hearing/vestibular/ear phenotype | 1.56e-05 | 905 | 31 | 10 | MP:0005377 | |
| MousePheno | abnormal ear morphology | 6.06e-05 | 470 | 31 | 7 | MP:0002102 | |
| MousePheno | persistent hyperplastic primary vitreous | 7.10e-05 | 6 | 31 | 2 | MP:0010711 | |
| MousePheno | abnormal primary vitreous morphology | 9.93e-05 | 7 | 31 | 2 | MP:0009620 | |
| MousePheno | perinatal lethality | 1.05e-04 | 1130 | 31 | 10 | MP:0002081 | |
| MousePheno | fusion of atlas and odontoid process | 2.12e-04 | 10 | 31 | 2 | MP:0010701 | |
| MousePheno | abnormal keratinocyte morphology | 2.27e-04 | 54 | 31 | 3 | MP:0002655 | |
| MousePheno | fusion of vertebral arches | 3.26e-04 | 61 | 31 | 3 | MP:0004613 | |
| MousePheno | abnormal intervertebral disk morphology | 4.30e-04 | 67 | 31 | 3 | MP:0004173 | |
| MousePheno | vertebral fusion | 4.39e-04 | 163 | 31 | 4 | MP:0004609 | |
| MousePheno | abnormal cricoid cartilage morphology | 4.91e-04 | 15 | 31 | 2 | MP:0002258 | |
| MousePheno | abnormal inner ear morphology | 4.95e-04 | 303 | 31 | 5 | MP:0000026 | |
| MousePheno | abnormal symphysis morphology | 5.10e-04 | 71 | 31 | 3 | MP:0030877 | |
| MousePheno | fused joints | 5.14e-04 | 170 | 31 | 4 | MP:0003189 | |
| MousePheno | increased depression-related behavior | 5.53e-04 | 73 | 31 | 3 | MP:0014414 | |
| MousePheno | abnormal ear physiology | 6.11e-04 | 684 | 31 | 7 | MP:0003878 | |
| Domain | zf-C4 | 7.27e-17 | 46 | 34 | 9 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 7.27e-17 | 46 | 34 | 9 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 7.27e-17 | 46 | 34 | 9 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 7.27e-17 | 46 | 34 | 9 | IPR001723 | |
| Domain | ZnF_C4 | 7.27e-17 | 46 | 34 | 9 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 7.27e-17 | 46 | 34 | 9 | PS51030 | |
| Domain | - | 8.98e-17 | 47 | 34 | 9 | 1.10.565.10 | |
| Domain | HOLI | 1.10e-16 | 48 | 34 | 9 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.10e-16 | 48 | 34 | 9 | IPR000536 | |
| Domain | Hormone_recep | 1.10e-16 | 48 | 34 | 9 | PF00104 | |
| Domain | - | 5.85e-16 | 57 | 34 | 9 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 6.92e-16 | 58 | 34 | 9 | IPR013088 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.91e-09 | 10 | 34 | 4 | IPR000003 | |
| Domain | EGF | 3.07e-06 | 126 | 34 | 5 | PF00008 | |
| Domain | Cezanne-2 | 3.22e-06 | 2 | 34 | 2 | IPR033477 | |
| Domain | Nuc_recep-AF1 | 3.22e-06 | 2 | 34 | 2 | PF11825 | |
| Domain | Nuc_recep-AF1 | 3.22e-06 | 2 | 34 | 2 | IPR021780 | |
| Domain | EGF | 3.73e-06 | 235 | 34 | 6 | SM00181 | |
| Domain | EGF-like_dom | 5.20e-06 | 249 | 34 | 6 | IPR000742 | |
| Domain | Nuc_orph_rcpt | 9.64e-06 | 3 | 34 | 2 | IPR003070 | |
| Domain | Retinoic_acid_rcpt | 1.93e-05 | 4 | 34 | 2 | IPR003078 | |
| Domain | Laminin_EGF | 3.47e-05 | 35 | 34 | 3 | PF00053 | |
| Domain | EGF_Lam | 3.47e-05 | 35 | 34 | 3 | SM00180 | |
| Domain | Laminin_EGF | 4.45e-05 | 38 | 34 | 3 | IPR002049 | |
| Domain | EGF_3 | 6.24e-05 | 235 | 34 | 5 | PS50026 | |
| Domain | Znf_A20 | 6.72e-05 | 7 | 34 | 2 | IPR002653 | |
| Domain | ZF_A20 | 6.72e-05 | 7 | 34 | 2 | PS51036 | |
| Domain | ZnF_A20 | 6.72e-05 | 7 | 34 | 2 | SM00259 | |
| Domain | zf-A20 | 6.72e-05 | 7 | 34 | 2 | PF01754 | |
| Domain | EGF_1 | 9.18e-05 | 255 | 34 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.02e-04 | 261 | 34 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.10e-04 | 265 | 34 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 1.79e-04 | 156 | 34 | 4 | IPR009030 | |
| Domain | OTU | 2.48e-04 | 13 | 34 | 2 | PF02338 | |
| Domain | OTU | 3.33e-04 | 15 | 34 | 2 | PS50802 | |
| Domain | OTU_dom | 3.33e-04 | 15 | 34 | 2 | IPR003323 | |
| Domain | EGF_LAM_2 | 1.36e-03 | 30 | 34 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.36e-03 | 30 | 34 | 2 | PS01248 | |
| Domain | EGF_CA | 1.40e-03 | 122 | 34 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.47e-03 | 124 | 34 | 3 | IPR001881 | |
| Domain | fn3 | 3.15e-03 | 162 | 34 | 3 | PF00041 | |
| Domain | FN3 | 4.57e-03 | 185 | 34 | 3 | SM00060 | |
| Domain | EGF_extracell | 5.33e-03 | 60 | 34 | 2 | IPR013111 | |
| Domain | EGF_2 | 5.33e-03 | 60 | 34 | 2 | PF07974 | |
| Domain | FN3 | 5.59e-03 | 199 | 34 | 3 | PS50853 | |
| Domain | UBA-like | 6.04e-03 | 64 | 34 | 2 | IPR009060 | |
| Domain | FN3_dom | 6.40e-03 | 209 | 34 | 3 | IPR003961 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.80e-16 | 53 | 28 | 9 | M8276 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.89e-14 | 48 | 28 | 8 | MM14987 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 1.27e-13 | 6 | 28 | 5 | M48097 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 9.15e-11 | 38 | 28 | 6 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 9.15e-11 | 38 | 28 | 6 | MM15865 | |
| Pathway | PID_RXR_VDR_PATHWAY | 1.36e-09 | 26 | 28 | 5 | M162 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.92e-09 | 30 | 28 | 5 | M207 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 1.94e-08 | 43 | 28 | 5 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.94e-08 | 43 | 28 | 5 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 2.18e-08 | 44 | 28 | 5 | MM15851 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.81e-08 | 49 | 28 | 5 | MM15186 | |
| Pathway | KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION | 7.00e-08 | 5 | 28 | 3 | M49023 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 3.29e-07 | 30 | 28 | 4 | M27323 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 5.85e-07 | 9 | 28 | 3 | M47629 | |
| Pathway | PID_AR_TF_PATHWAY | 3.41e-06 | 53 | 28 | 4 | M151 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 3.68e-06 | 54 | 28 | 4 | M19818 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.09e-05 | 768 | 28 | 9 | MM14851 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.17e-05 | 72 | 28 | 4 | M39738 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.15e-05 | 84 | 28 | 4 | M3228 | |
| Pathway | KEGG_THYROID_CANCER | 2.48e-05 | 29 | 28 | 3 | M523 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 3.31e-05 | 191 | 28 | 5 | MM15586 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.52e-05 | 325 | 28 | 6 | M12868 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.65e-05 | 96 | 28 | 4 | M39834 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS | 3.79e-05 | 5 | 28 | 2 | M29812 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE | 3.79e-05 | 5 | 28 | 2 | M29791 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE | 3.79e-05 | 5 | 28 | 2 | M29792 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 5.68e-05 | 6 | 28 | 2 | MM1447 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 5.68e-05 | 6 | 28 | 2 | MM15659 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 5.68e-05 | 6 | 28 | 2 | MM15663 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 7.94e-05 | 7 | 28 | 2 | M6907 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 9.31e-05 | 122 | 28 | 4 | M29689 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.01e-04 | 46 | 28 | 3 | M239 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.05e-04 | 1022 | 28 | 9 | MM15436 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.36e-04 | 9 | 28 | 2 | M29809 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS | 1.36e-04 | 9 | 28 | 2 | M29789 | |
| Pathway | WP_VITAMIN_D_METABOLISM | 1.70e-04 | 10 | 28 | 2 | M39352 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.05e-04 | 1387 | 28 | 10 | M734 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.07e-04 | 11 | 28 | 2 | MM1521 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.07e-04 | 11 | 28 | 2 | MM1432 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M18837 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 2.23e-04 | 60 | 28 | 3 | M40048 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.48e-04 | 12 | 28 | 2 | M7968 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 2.61e-04 | 296 | 28 | 5 | M27869 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.93e-04 | 13 | 28 | 2 | MM15622 | |
| Pathway | WP_PPAR_SIGNALING | 3.09e-04 | 67 | 28 | 3 | M39553 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 3.09e-04 | 67 | 28 | 3 | M10462 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 3.37e-04 | 69 | 28 | 3 | M13088 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 3.98e-04 | 73 | 28 | 3 | MM15995 | |
| Pathway | WP_CANCER_PATHWAYS | 4.03e-04 | 507 | 28 | 6 | M48302 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 4.31e-04 | 75 | 28 | 3 | M39568 | |
| Pathway | REACTOME_SUMOYLATION | 4.98e-04 | 189 | 28 | 4 | M27214 | |
| Pathway | WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING | 8.57e-04 | 22 | 28 | 2 | M39345 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.20e-03 | 26 | 28 | 2 | MM14793 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.39e-03 | 28 | 28 | 2 | M48253 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.39e-03 | 28 | 28 | 2 | MM15042 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 1.60e-03 | 30 | 28 | 2 | MM15866 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 1.82e-03 | 32 | 28 | 2 | MM15290 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.93e-03 | 33 | 28 | 2 | MM1448 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 2.05e-03 | 34 | 28 | 2 | M16393 | |
| Pathway | WP_ADIPOGENESIS | 2.17e-03 | 131 | 28 | 3 | M39505 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 2.17e-03 | 35 | 28 | 2 | M39488 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.43e-03 | 37 | 28 | 2 | M29790 | |
| Pathway | WP_ADIPOGENESIS_GENES | 2.46e-03 | 137 | 28 | 3 | MM15970 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 2.69e-03 | 39 | 28 | 2 | M27579 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.12e-03 | 42 | 28 | 2 | M27272 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.68e-03 | 158 | 28 | 3 | MM14791 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.89e-03 | 47 | 28 | 2 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 4.22e-03 | 49 | 28 | 2 | M48250 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 6.07e-03 | 59 | 28 | 2 | M46460 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.27e-03 | 60 | 28 | 2 | MM14872 | |
| Pubmed | 3.83e-18 | 7 | 34 | 6 | 15635645 | ||
| Pubmed | Retinoic acid signaling is necessary for the development of the organ of Corti. | 6.56e-16 | 5 | 34 | 5 | 10452855 | |
| Pubmed | Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. | 3.94e-15 | 6 | 34 | 5 | 11328745 | |
| Pubmed | 3.94e-15 | 6 | 34 | 5 | 9153406 | ||
| Pubmed | Spatial distributions of retinoic acid receptor gene transcripts in the prenatal mouse inner ear. | 3.94e-15 | 6 | 34 | 5 | 9548551 | |
| Pubmed | Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis. | 3.94e-15 | 6 | 34 | 5 | 9464546 | |
| Pubmed | Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. | 3.94e-15 | 6 | 34 | 5 | 20557428 | |
| Pubmed | 3.94e-15 | 6 | 34 | 5 | 8801169 | ||
| Pubmed | 3.94e-15 | 6 | 34 | 5 | 8801176 | ||
| Pubmed | The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. | 3.94e-15 | 6 | 34 | 5 | 9806918 | |
| Pubmed | A genetic dissection of the retinoid signalling pathway in the mouse. | 3.94e-15 | 6 | 34 | 5 | 10604193 | |
| Pubmed | 3.94e-15 | 6 | 34 | 5 | 9075714 | ||
| Pubmed | 1.38e-14 | 7 | 34 | 5 | 9428411 | ||
| Pubmed | Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. | 1.38e-14 | 7 | 34 | 5 | 11493527 | |
| Pubmed | 1.38e-14 | 7 | 34 | 5 | 12360493 | ||
| Pubmed | 1.38e-14 | 7 | 34 | 5 | 17195188 | ||
| Pubmed | 1.38e-14 | 7 | 34 | 5 | 8090775 | ||
| Pubmed | 3.67e-14 | 8 | 34 | 5 | 10490294 | ||
| Pubmed | Expression of nuclear retinoic acid receptors during mouse odontogenesis. | 3.67e-14 | 8 | 34 | 5 | 7988794 | |
| Pubmed | Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. | 3.67e-14 | 8 | 34 | 5 | 10094571 | |
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 3.67e-14 | 8 | 34 | 5 | 17124491 | |
| Pubmed | 5.76e-14 | 263 | 34 | 10 | 20932939 | ||
| Pubmed | 8.25e-14 | 9 | 34 | 5 | 7823919 | ||
| Pubmed | 3.02e-13 | 11 | 34 | 5 | 29093497 | ||
| Pubmed | 5.17e-13 | 12 | 34 | 5 | 9022057 | ||
| Pubmed | 5.17e-13 | 12 | 34 | 5 | 26427057 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 6.17e-13 | 133 | 34 | 8 | 15604093 | |
| Pubmed | Regulation of prefrontal patterning and connectivity by retinoic acid. | 7.22e-13 | 34 | 34 | 6 | 34599305 | |
| Pubmed | Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice. | 7.61e-13 | 4 | 34 | 4 | 10079186 | |
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 8524212 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 9348290 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 7967725 | ||
| Pubmed | 1.31e-12 | 14 | 34 | 5 | 18561907 | ||
| Pubmed | 1.31e-12 | 14 | 34 | 5 | 18393306 | ||
| Pubmed | 1.31e-12 | 14 | 34 | 5 | 21923909 | ||
| Pubmed | 1.96e-12 | 15 | 34 | 5 | 19448158 | ||
| Pubmed | 2.85e-12 | 16 | 34 | 5 | 25577283 | ||
| Pubmed | 2.85e-12 | 16 | 34 | 5 | 11795391 | ||
| Pubmed | A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. | 3.80e-12 | 5 | 34 | 4 | 7705655 | |
| Pubmed | Developmental expression of murine retinoid X receptor (RXR) genes. | 3.80e-12 | 5 | 34 | 4 | 8199055 | |
| Pubmed | 3.80e-12 | 5 | 34 | 4 | 9053308 | ||
| Pubmed | 1.01e-11 | 20 | 34 | 5 | 19605690 | ||
| Pubmed | 1.14e-11 | 6 | 34 | 4 | 16428452 | ||
| Pubmed | Nuclear receptors in Leydig cell gene expression and function. | 1.71e-11 | 22 | 34 | 5 | 20375256 | |
| Pubmed | 1.71e-11 | 22 | 34 | 5 | 10753524 | ||
| Pubmed | 2.15e-11 | 118 | 34 | 7 | 16971476 | ||
| Pubmed | 2.18e-11 | 23 | 34 | 5 | 19737349 | ||
| Pubmed | 2.66e-11 | 7 | 34 | 4 | 10406480 | ||
| Pubmed | 2.66e-11 | 7 | 34 | 4 | 8299717 | ||
| Pubmed | Diverse Functions of Retinoic Acid in Brain Vascular Development. | 6.35e-11 | 28 | 34 | 5 | 27445154 | |
| Pubmed | 1.30e-10 | 32 | 34 | 5 | 17270348 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 1.59e-10 | 10 | 34 | 4 | 25303530 | |
| Pubmed | Unique response pathways are established by allosteric interactions among nuclear hormone receptors. | 8.54e-10 | 3 | 34 | 3 | 7758108 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 7831303 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 23969901 | ||
| Pubmed | Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. | 8.54e-10 | 3 | 34 | 3 | 1312497 | |
| Pubmed | Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. | 8.54e-10 | 3 | 34 | 3 | 7980510 | |
| Pubmed | Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. | 8.54e-10 | 3 | 34 | 3 | 12514092 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 11053444 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 15528208 | ||
| Pubmed | Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. | 8.54e-10 | 3 | 34 | 3 | 9452386 | |
| Pubmed | Retinoid X receptors: X-ploring their (patho)physiological functions. | 8.54e-10 | 3 | 34 | 3 | 15608692 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 8034312 | ||
| Pubmed | Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. | 8.54e-10 | 3 | 34 | 3 | 15255287 | |
| Pubmed | Retinoid receptors trigger neuritogenesis in retinal degenerations. | 8.54e-10 | 3 | 34 | 3 | 21940995 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 11839661 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 9883728 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 8799145 | ||
| Pubmed | 9.82e-10 | 709 | 34 | 10 | 22988430 | ||
| Pubmed | 2.21e-09 | 55 | 34 | 5 | 34292881 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 1310259 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 11641790 | ||
| Pubmed | Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. | 3.41e-09 | 4 | 34 | 3 | 22022577 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 26355550 | ||
| Pubmed | Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. | 3.41e-09 | 4 | 34 | 3 | 19686701 | |
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 12093741 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 9804293 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 10611353 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 12549917 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 9376317 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 10869350 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 19665987 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 1331778 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 8961274 | ||
| Pubmed | 8.52e-09 | 5 | 34 | 3 | 19345331 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.04e-08 | 908 | 34 | 10 | 19274049 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 22205725 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 8563020 | ||
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 7947324 | ||
| Pubmed | Mesenchymal/epithelial regulation of retinoic acid signaling in the olfactory placode. | 1.70e-08 | 6 | 34 | 3 | 12941622 | |
| Pubmed | Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. | 2.98e-08 | 7 | 34 | 3 | 24610012 | |
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 12665583 | ||
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 12204252 | ||
| Pubmed | 2.98e-08 | 7 | 34 | 3 | 10449983 | ||
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 8616895 | ||
| Pubmed | 4.76e-08 | 8 | 34 | 3 | 16043864 | ||
| Pubmed | 4.91e-08 | 37 | 34 | 4 | 20236931 | ||
| Pubmed | 4.91e-08 | 37 | 34 | 4 | 38011284 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 9346901 | ||
| Pubmed | 7.14e-08 | 9 | 34 | 3 | 22539306 | ||
| Interaction | RARB interactions | 1.31e-08 | 46 | 34 | 5 | int:RARB | |
| Interaction | RARG interactions | 4.32e-08 | 58 | 34 | 5 | int:RARG | |
| Interaction | NCOA1 interactions | 1.48e-07 | 146 | 34 | 6 | int:NCOA1 | |
| Interaction | NR1H4 interactions | 2.35e-07 | 32 | 34 | 4 | int:NR1H4 | |
| Interaction | NR0B2 interactions | 2.66e-07 | 83 | 34 | 5 | int:NR0B2 | |
| Interaction | NRIP1 interactions | 3.65e-07 | 170 | 34 | 6 | int:NRIP1 | |
| Interaction | TGIF1 interactions | 6.54e-07 | 41 | 34 | 4 | int:TGIF1 | |
| Interaction | RXRG interactions | 1.14e-06 | 47 | 34 | 4 | int:RXRG | |
| Interaction | RARA interactions | 1.78e-06 | 223 | 34 | 6 | int:RARA | |
| Interaction | NR1H3 interactions | 2.69e-06 | 58 | 34 | 4 | int:NR1H3 | |
| Interaction | RXRB interactions | 4.52e-06 | 66 | 34 | 4 | int:RXRB | |
| Interaction | NR1H2 interactions | 5.09e-06 | 68 | 34 | 4 | int:NR1H2 | |
| Interaction | NR2E3 interactions | 5.72e-06 | 21 | 34 | 3 | int:NR2E3 | |
| Interaction | RXRA interactions | 8.93e-06 | 169 | 34 | 5 | int:RXRA | |
| Interaction | PPARG interactions | 1.12e-05 | 307 | 34 | 6 | int:PPARG | |
| Interaction | NR4A2 interactions | 1.25e-05 | 27 | 34 | 3 | int:NR4A2 | |
| Interaction | NCOA3 interactions | 3.47e-05 | 224 | 34 | 5 | int:NCOA3 | |
| Interaction | THRA interactions | 3.56e-05 | 111 | 34 | 4 | int:THRA | |
| Interaction | WNT8B interactions | 4.13e-05 | 6 | 34 | 2 | int:WNT8B | |
| Interaction | TNNI2 interactions | 4.15e-05 | 40 | 34 | 3 | int:TNNI2 | |
| Interaction | NR1I2 interactions | 7.20e-05 | 48 | 34 | 3 | int:NR1I2 | |
| Interaction | NCOR2 interactions | 7.57e-05 | 264 | 34 | 5 | int:NCOR2 | |
| Interaction | TLX2 interactions | 9.30e-05 | 142 | 34 | 4 | int:TLX2 | |
| Interaction | NCOA6 interactions | 1.01e-04 | 145 | 34 | 4 | int:NCOA6 | |
| Interaction | TLX3 interactions | 1.20e-04 | 291 | 34 | 5 | int:TLX3 | |
| Interaction | PSMC5 interactions | 1.41e-04 | 484 | 34 | 6 | int:PSMC5 | |
| Interaction | LHX3 interactions | 2.57e-04 | 185 | 34 | 4 | int:LHX3 | |
| Interaction | KLF5 interactions | 3.14e-04 | 195 | 34 | 4 | int:KLF5 | |
| Interaction | GADD45G interactions | 3.18e-04 | 79 | 34 | 3 | int:GADD45G | |
| Interaction | GATA2 interactions | 3.39e-04 | 199 | 34 | 4 | int:GATA2 | |
| Interaction | PPARGC1A interactions | 3.55e-04 | 82 | 34 | 3 | int:PPARGC1A | |
| Interaction | ORC5 interactions | 4.22e-04 | 87 | 34 | 3 | int:ORC5 | |
| Interaction | KCTD16 interactions | 4.64e-04 | 19 | 34 | 2 | int:KCTD16 | |
| Interaction | PPARA interactions | 4.97e-04 | 92 | 34 | 3 | int:PPARA | |
| Interaction | SIX3 interactions | 5.15e-04 | 20 | 34 | 2 | int:SIX3 | |
| Interaction | GRIP1 interactions | 5.63e-04 | 96 | 34 | 3 | int:GRIP1 | |
| Interaction | PNRC1 interactions | 6.84e-04 | 23 | 34 | 2 | int:PNRC1 | |
| Interaction | ALOX15B interactions | 6.84e-04 | 23 | 34 | 2 | int:ALOX15B | |
| Interaction | SMARCD3 interactions | 7.72e-04 | 107 | 34 | 3 | int:SMARCD3 | |
| GeneFamily | Nuclear hormone receptors | 2.41e-17 | 49 | 28 | 9 | 71 | |
| GeneFamily | OTU domain containing | 3.10e-04 | 17 | 28 | 2 | 669 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 7.93e-04 | 27 | 28 | 2 | 1253 | |
| GeneFamily | Fibronectin type III domain containing | 1.89e-03 | 160 | 28 | 3 | 555 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP | 2.98e-06 | 175 | 34 | 5 | M6684 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN | 1.89e-05 | 256 | 34 | 5 | M41152 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN | 2.73e-05 | 45 | 34 | 3 | M10084 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 7.45e-05 | 174 | 34 | 4 | M2038 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN | 8.68e-05 | 181 | 34 | 4 | M40912 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 9.05e-05 | 183 | 34 | 4 | M7627 | |
| Coexpression | GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 9.05e-05 | 183 | 34 | 4 | M7635 | |
| Coexpression | GSE11057_CD4_EFF_MEM_VS_PBMC_DN | 1.13e-04 | 194 | 34 | 4 | M3114 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 1.23e-04 | 198 | 34 | 4 | M9778 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP | 1.23e-04 | 198 | 34 | 4 | M7948 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN | 1.28e-04 | 200 | 34 | 4 | M9901 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN | 1.28e-04 | 200 | 34 | 4 | M9385 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 3.67e-07 | 441 | 34 | 8 | GSM605862_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 2.18e-05 | 364 | 34 | 6 | GSM854276_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 4.31e-05 | 411 | 34 | 6 | GSM538239_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 4.49e-05 | 414 | 34 | 6 | GSM854271_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 5.12e-05 | 424 | 34 | 6 | GSM854294_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 5.76e-05 | 433 | 34 | 6 | GSM605856_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.06e-05 | 437 | 34 | 6 | GSM605865_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 6.13e-05 | 438 | 34 | 6 | GSM605850_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103+ F4/80-lo, Small Intestine, avg-4 | 1.09e-04 | 58 | 34 | 3 | GSM854237_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5 | 1.83e-04 | 69 | 34 | 3 | GSM854232_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4 | 2.80e-04 | 368 | 34 | 5 | GSM854258_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 3.40e-04 | 384 | 34 | 5 | GSM605820_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 3.51e-04 | 86 | 34 | 3 | GSM605850_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.75e-04 | 88 | 34 | 3 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k2_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 3.76e-04 | 1466 | 34 | 9 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 4.54e-04 | 409 | 34 | 5 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 5.47e-04 | 426 | 34 | 5 | GSM605859_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.14e-04 | 437 | 34 | 5 | GSM777046_500 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-07 | 171 | 34 | 5 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.84e-07 | 197 | 34 | 5 | 6f83fc049f38f3de6bc5180ad4b51ceb4d5dcdb6 | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group,lineage and cell class （2021.01.30） | 3.84e-07 | 197 | 34 | 5 | aef933107da42a763b35041c90950db07707c0cb | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.84e-07 | 197 | 34 | 5 | 15e683f4a610aad3e06723747c8e56ca25f57414 | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.84e-07 | 197 | 34 | 5 | 6ac50c02899531a25885749d5305da788dfa9dbc | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.84e-07 | 197 | 34 | 5 | 513ada82bbbb6a624d89edaa54f8c4a303dfb5e7 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-06 | 160 | 34 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.07e-06 | 163 | 34 | 4 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.35e-06 | 170 | 34 | 4 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.75e-06 | 172 | 34 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.79e-06 | 177 | 34 | 4 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-05 | 179 | 34 | 4 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-05 | 179 | 34 | 4 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 180 | 34 | 4 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 183 | 34 | 4 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 183 | 34 | 4 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.19e-05 | 186 | 34 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 187 | 34 | 4 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 187 | 34 | 4 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 189 | 34 | 4 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 190 | 34 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 190 | 34 | 4 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | (3)_MNP-(3)_DC_2|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.32e-05 | 191 | 34 | 4 | 3ff163484af8c12ef4eef87246cf044257fd2547 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | 367C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 192 | 34 | 4 | 877aaf61d8fc40e7013944a0180306dd0bb0557f | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 192 | 34 | 4 | a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 192 | 34 | 4 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 192 | 34 | 4 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 192 | 34 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.40e-05 | 194 | 34 | 4 | 28571cf24b8a1d0ffb716167b977d420868cc874 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 194 | 34 | 4 | aa6c9b71006fd3863a802d112d9c3838865a52bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-05 | 194 | 34 | 4 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.43e-05 | 195 | 34 | 4 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | 9cfbdb528088ad0ab100c7431c7d8f140a846de8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 195 | 34 | 4 | c9469e2d31beb30ebb64b3f0a5239e23119fbaa5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | 66f3b3e15eaa21bc7cf2f204cac81de1a160a748 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 195 | 34 | 4 | 2f2e29089a8cb748d2c1329c5c8465165b25bc8b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 195 | 34 | 4 | bbf5f79be4fcea754328f1af7ee5625075248100 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 196 | 34 | 4 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue | 1.46e-05 | 196 | 34 | 4 | fede2c605f7581ce2ea7a284cffffa1a3970d811 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 196 | 34 | 4 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 196 | 34 | 4 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 196 | 34 | 4 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | Control-Myeloid-DC2|Control / Condition, Lineage and Cell class | 1.46e-05 | 196 | 34 | 4 | 0ccc26c2811e4c8631e0abd8555b167ac1e7a982 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 196 | 34 | 4 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 196 | 34 | 4 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.49e-05 | 197 | 34 | 4 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | Control-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 1.49e-05 | 197 | 34 | 4 | e0ee15188ff0d9df3c3b5ea523553ce18d223c33 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 197 | 34 | 4 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 197 | 34 | 4 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.52e-05 | 198 | 34 | 4 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 198 | 34 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.55e-05 | 199 | 34 | 4 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 199 | 34 | 4 | fdd8c4c04837341e17a4772a2adcdf2f187c56b1 | |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.58e-05 | 200 | 34 | 4 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.35e-04 | 131 | 34 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-04 | 132 | 34 | 3 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-04 | 134 | 34 | 3 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.48e-04 | 135 | 34 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-3|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.51e-04 | 136 | 34 | 3 | 4f5e0b6c7d6e3e922af4daa7c3eb56490455c1df | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.51e-04 | 136 | 34 | 3 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 138 | 34 | 3 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.64e-04 | 140 | 34 | 3 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-04 | 141 | 34 | 3 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 142 | 34 | 3 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 142 | 34 | 3 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-04 | 143 | 34 | 3 | 7adc34d8ad11e57950a5a258ae9bf8f52259385a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-04 | 143 | 34 | 3 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-04 | 145 | 34 | 3 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-04 | 151 | 34 | 3 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 152 | 34 | 3 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 157 | 34 | 3 | ad8c6eb34f5288288c4066119c17325afefbaafc | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 2.35e-04 | 158 | 34 | 3 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 159 | 34 | 3 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 160 | 34 | 3 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.48e-04 | 161 | 34 | 3 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 161 | 34 | 3 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 161 | 34 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 161 | 34 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 161 | 34 | 3 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 161 | 34 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-04 | 161 | 34 | 3 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 2.48e-04 | 161 | 34 | 3 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 2.48e-04 | 161 | 34 | 3 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 161 | 34 | 3 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.53e-04 | 162 | 34 | 3 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-04 | 162 | 34 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 2.57e-04 | 163 | 34 | 3 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.57e-04 | 163 | 34 | 3 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 163 | 34 | 3 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 164 | 34 | 3 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.62e-04 | 164 | 34 | 3 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.71e-04 | 166 | 34 | 3 | d638d356592325cded4a6cb549041cf2f8d3e62c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-04 | 166 | 34 | 3 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.71e-04 | 166 | 34 | 3 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-04 | 166 | 34 | 3 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| Computational | Genes in the cancer module 27. | 1.54e-05 | 355 | 26 | 7 | MODULE_27 | |
| Computational | Steroid hormone receptors and binding proteins. | 3.15e-05 | 26 | 26 | 3 | MODULE_404 | |
| Computational | Genes in the cancer module 257. | 4.98e-04 | 156 | 26 | 4 | MODULE_257 | |
| Drug | HX 630 | 1.45e-15 | 10 | 34 | 6 | ctd:C422175 | |
| Drug | Alitretinoin | 3.27e-14 | 6 | 34 | 5 | DB00523 | |
| Drug | Adapalene | 3.27e-14 | 6 | 34 | 5 | DB00210 | |
| Drug | Etretinate | 3.27e-14 | 6 | 34 | 5 | DB00926 | |
| Drug | Acitretin | 1.14e-13 | 7 | 34 | 5 | DB00459 | |
| Drug | HX600 | 1.28e-13 | 18 | 34 | 6 | CID000128016 | |
| Drug | HX 600 | 3.05e-13 | 8 | 34 | 5 | ctd:C104181 | |
| Drug | TTNN | 3.05e-13 | 8 | 34 | 5 | CID000135754 | |
| Drug | adapalene | 5.10e-13 | 22 | 34 | 6 | CID000060164 | |
| Drug | AC1L2X6Z | 2.01e-12 | 27 | 34 | 6 | CID000130325 | |
| Drug | UVI 3003 | 2.51e-12 | 11 | 34 | 5 | ctd:C525131 | |
| Drug | Cd2665 | 6.97e-12 | 13 | 34 | 5 | CID000216241 | |
| Drug | AC1L1DMQ | 1.08e-11 | 14 | 34 | 5 | CID000002418 | |
| Drug | tazarotene | 2.58e-11 | 40 | 34 | 6 | CID000005381 | |
| Drug | Ro 15-0778 | 1.80e-10 | 23 | 34 | 5 | CID006436116 | |
| Drug | AC1O5JP6 | 2.89e-10 | 8 | 34 | 4 | CID006435379 | |
| Drug | AC1L2E0P | 5.11e-10 | 307 | 34 | 9 | CID000019390 | |
| Drug | AGN 193109 | 9.02e-10 | 31 | 34 | 5 | CID000177238 | |
| Drug | CD367 | 1.26e-09 | 33 | 34 | 5 | CID000119342 | |
| Drug | DR-0 | 1.72e-09 | 35 | 34 | 5 | CID010062716 | |
| Drug | A-74702 | 1.93e-09 | 80 | 34 | 6 | CID000452307 | |
| Drug | Ro 41-5253 | 2.30e-09 | 37 | 34 | 5 | CID005312120 | |
| Drug | tazarotenic acid | 2.93e-09 | 13 | 34 | 4 | CID000147525 | |
| Drug | tamibarotene | 3.01e-09 | 86 | 34 | 6 | CID000108143 | |
| Drug | Bexarotene | 3.04e-09 | 3 | 34 | 3 | DB00307 | |
| Drug | 2-hydroxyphytanic acid | 3.04e-09 | 3 | 34 | 3 | ctd:C002585 | |
| Drug | AC1O5SBP | 3.04e-09 | 3 | 34 | 3 | CID006439746 | |
| Drug | vitamin D3 analog | 3.94e-09 | 41 | 34 | 5 | CID006438384 | |
| Drug | Etretinate-d3 | 6.39e-09 | 45 | 34 | 5 | CID000003312 | |
| Drug | S-(+)-Methoprene | 7.17e-09 | 46 | 34 | 5 | CID000038532 | |
| Drug | AGN 190727 | 1.22e-08 | 4 | 34 | 3 | CID006439768 | |
| Drug | Tazarotene | 1.22e-08 | 4 | 34 | 3 | DB00799 | |
| Drug | epicholesterol | 1.93e-08 | 636 | 34 | 10 | CID000000304 | |
| Drug | AC1Q6CTU | 2.04e-08 | 118 | 34 | 6 | CID000021362 | |
| Drug | diheptyl phthalate | 2.44e-08 | 21 | 34 | 4 | ctd:C089799 | |
| Drug | CV-1 | 2.47e-08 | 213 | 34 | 7 | CID000130105 | |
| Drug | Betamethasone-d5 | LRP1 NR2C1 FNDC3A RARA RARB HNF4G SCARF2 PTGS1 ENPP1 RXRA RXRB RXRG STAB1 | 2.78e-08 | 1340 | 34 | 13 | CID000003003 |
| Drug | 7-methoxycitronellal | 3.04e-08 | 5 | 34 | 3 | CID000019223 | |
| Drug | 7-methoxycitronellic acid | 3.04e-08 | 5 | 34 | 3 | CID000171516 | |
| Drug | 13,14-dihydroretinol | 3.04e-08 | 5 | 34 | 3 | CID000446798 | |
| Drug | AC1L9M5J | 3.18e-08 | 221 | 34 | 7 | CID000448615 | |
| Drug | retinamide | 5.73e-08 | 69 | 34 | 5 | CID005370221 | |
| Drug | Prt-H | 6.05e-08 | 26 | 34 | 4 | CID003050291 | |
| Drug | triphenyltin hydroxide | 6.07e-08 | 6 | 34 | 3 | ctd:C007567 | |
| Drug | 9-cis-acitretin | 6.63e-08 | 71 | 34 | 5 | CID000041317 | |
| Drug | AGN 191659 | 1.06e-07 | 7 | 34 | 3 | CID006366726 | |
| Drug | AGN 190121 | 1.06e-07 | 7 | 34 | 3 | CID006441236 | |
| Drug | AC1L1KPQ | 1.07e-07 | 78 | 34 | 5 | CID000005602 | |
| Drug | sodium cholate | 1.20e-07 | 408 | 34 | 8 | CID000000303 | |
| Drug | vitamin D3 | 1.49e-07 | 277 | 34 | 7 | CID000002735 | |
| Drug | Retinoids | 1.86e-07 | 34 | 34 | 4 | ctd:D012176 | |
| Drug | ecdysone | 2.35e-07 | 178 | 34 | 6 | CID000019212 | |
| Drug | retinyl methyl ether | 2.54e-07 | 9 | 34 | 3 | CID006436634 | |
| Drug | alitretinoin | 2.61e-07 | 301 | 34 | 7 | ctd:C103303 | |
| Drug | eq N | 2.73e-07 | 94 | 34 | 5 | CID000002126 | |
| Drug | 3,5-di-tert-butylchalcone 4'-carboxylic acid | 3.62e-07 | 10 | 34 | 3 | ctd:C054189 | |
| Drug | diazepinylbenzoic acid | 3.62e-07 | 10 | 34 | 3 | ctd:C438269 | |
| Drug | acyclic retinoid | 4.04e-07 | 41 | 34 | 4 | CID006437836 | |
| Drug | Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A | 4.53e-07 | 199 | 34 | 6 | 3878_UP | |
| Drug | AGN 191701 | 4.98e-07 | 11 | 34 | 3 | CID006438168 | |
| Drug | Musk T | 4.98e-07 | 11 | 34 | 3 | CID000061014 | |
| Drug | tris | 6.04e-07 | 209 | 34 | 6 | CID000006503 | |
| Drug | di-n-propylphthalate | 6.63e-07 | 12 | 34 | 3 | ctd:C106479 | |
| Drug | NSC46155 | 6.63e-07 | 12 | 34 | 3 | CID000457869 | |
| Drug | 9-cis-retinol | 8.21e-07 | 357 | 34 | 7 | CID000001071 | |
| Drug | troglitazone | 8.23e-07 | 526 | 34 | 8 | CID000005591 | |
| Drug | benzoate | 8.37e-07 | 221 | 34 | 6 | CID000000242 | |
| Drug | GW2331 | 8.61e-07 | 13 | 34 | 3 | CID000657048 | |
| Drug | DB04680 | 9.30e-07 | 225 | 34 | 6 | CID005326972 | |
| Drug | di-n-pentyl phthalate | 9.85e-07 | 51 | 34 | 4 | ctd:C034171 | |
| Drug | AC1L9K70 | 1.00e-06 | 228 | 34 | 6 | CID000446871 | |
| Drug | Sulfonamides | 1.10e-06 | 14 | 34 | 3 | ctd:D013449 | |
| Drug | AC1L1JB6 | 1.42e-06 | 131 | 34 | 5 | CID000004961 | |
| Drug | Fenretinide | 1.76e-06 | 251 | 34 | 6 | ctd:D017313 | |
| Drug | phthalic acid | 2.04e-06 | 17 | 34 | 3 | ctd:C032279 | |
| Drug | 9-HODE | 2.11e-06 | 142 | 34 | 5 | CID000001927 | |
| Drug | Ro 8-8717 | 2.16e-06 | 2 | 34 | 2 | CID006438148 | |
| Drug | Tamibarotene | 2.16e-06 | 2 | 34 | 2 | DB04942 | |
| Drug | 3,4-didehydroretinoic acid | 2.44e-06 | 18 | 34 | 3 | CID000447276 | |
| Drug | retinol palmitate | 2.44e-06 | 18 | 34 | 3 | ctd:C014794 | |
| Drug | androst-2-en-3-ol | 2.44e-06 | 18 | 34 | 3 | CID000166036 | |
| Drug | AC1L1C56 | 2.79e-06 | 272 | 34 | 6 | CID000001744 | |
| Drug | ponasterone A | 3.54e-06 | 70 | 34 | 4 | CID000115127 | |
| Drug | AC1L1JIR | 3.97e-06 | 72 | 34 | 4 | CID000005058 | |
| Drug | GW9662 | 4.16e-06 | 163 | 34 | 5 | CID000644213 | |
| Drug | di-n-hexyl phthalate | 4.60e-06 | 22 | 34 | 3 | ctd:C027387 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 4.68e-06 | 167 | 34 | 5 | 6187_UP | |
| Drug | ciglitazone | 4.96e-06 | 169 | 34 | 5 | CID000002750 | |
| Drug | Griseofulvin | 5.19e-06 | 77 | 34 | 4 | ctd:D006118 | |
| Drug | AC1L32JQ | 5.28e-06 | 23 | 34 | 3 | CID000133319 | |
| Drug | T0901317 | 6.36e-06 | 81 | 34 | 4 | CID000447912 | |
| Drug | Etodolac | 6.49e-06 | 3 | 34 | 2 | DB00749 | |
| Drug | scoparone | 6.84e-06 | 25 | 34 | 3 | CID000008417 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; HL60; HT_HG-U133A | 7.12e-06 | 182 | 34 | 5 | 1280_UP | |
| Drug | 11-cis-retinal | 8.56e-06 | 189 | 34 | 5 | CID000001070 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 9.00e-06 | 191 | 34 | 5 | 4190_UP | |
| Drug | rhod-2 | 9.72e-06 | 28 | 34 | 3 | CID000123669 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 9.95e-06 | 195 | 34 | 5 | 6183_UP | |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | 1.02e-05 | 196 | 34 | 5 | 6364_UP | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A | 1.05e-05 | 197 | 34 | 5 | 3815_UP | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 4.63e-09 | 4 | 32 | 3 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 4.63e-09 | 4 | 32 | 3 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 4.63e-09 | 4 | 32 | 3 | C0154748 | |
| Disease | Sciatic Neuritis | 4.63e-09 | 4 | 32 | 3 | C0242013 | |
| Disease | Sciatic Neuropathy | 4.63e-09 | 4 | 32 | 3 | C0149940 | |
| Disease | prostate carcinoma in situ (biomarker_via_orthology) | 6.83e-06 | 4 | 32 | 2 | DOID:8634 (biomarker_via_orthology) | |
| Disease | Phyllodes Tumor | 1.14e-05 | 5 | 32 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 1.14e-05 | 5 | 32 | 2 | C0600066 | |
| Disease | Malignant neoplasm of breast | 1.45e-05 | 1074 | 32 | 8 | C0006142 | |
| Disease | age at menarche | 3.77e-05 | 594 | 32 | 6 | EFO_0004703 | |
| Disease | Colorectal Carcinoma | 9.49e-05 | 702 | 32 | 6 | C0009402 | |
| Disease | Mammary Neoplasms, Human | 2.37e-04 | 525 | 32 | 5 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 2.37e-04 | 525 | 32 | 5 | C4704874 | |
| Disease | Mammary Neoplasms | 2.41e-04 | 527 | 32 | 5 | C1458155 | |
| Disease | Breast Carcinoma | 2.65e-04 | 538 | 32 | 5 | C0678222 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 3.86e-04 | 131 | 32 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 3.86e-04 | 131 | 32 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 3.86e-04 | 131 | 32 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 3.86e-04 | 131 | 32 | 3 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 4.22e-04 | 135 | 32 | 3 | C0087031 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.23e-04 | 28 | 32 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.59e-04 | 139 | 32 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | Endometrioma | 7.04e-04 | 161 | 32 | 3 | C0269102 | |
| Disease | Endometriosis | 7.04e-04 | 161 | 32 | 3 | C0014175 | |
| Disease | glioblastoma (is_marker_for) | 1.05e-03 | 44 | 32 | 2 | DOID:3068 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRFRCSFRQRDCAAH | 351 | Q14416 | |
| CAARRNFCDGRRCQN | 1646 | Q9NYQ6 | |
| CCLTYCFAPRCRERR | 261 | P33681 | |
| RCDRNFVYCNERSLT | 41 | O43155 | |
| QREACRRACCFARVE | 666 | O14983 | |
| HRNRCQYCRLQRCIA | 161 | P13056 | |
| TRNRCQYCRLQKCFE | 136 | P10276 | |
| TRNRCQYCRLQKCFE | 136 | P10826 | |
| NNFCSCCYREELRRR | 816 | Q6GQQ9 | |
| LGDRSQNRFRCECRY | 116 | Q8NDB6 | |
| QNRFRCECRYCQSHR | 121 | Q8NDB6 | |
| RQCRCTAYFEGSRCE | 4326 | Q07954 | |
| RCFERTFGNCRCDAA | 111 | P22413 | |
| VQRRCQRENCAFYGR | 886 | Q8TE49 | |
| CVRFGLDRYQCDCTR | 46 | P23219 | |
| RNQCRYCRLRKCFRA | 61 | Q14541 | |
| RFCDRVQDAYTLRCC | 386 | P42357 | |
| NCEYRFRVCAIRQCQ | 1111 | Q9Y2H6 | |
| YRFRVCACRRCLDTS | 1121 | Q53EP0 | |
| RNFHENCYRCEDCRI | 326 | Q8WUP2 | |
| DCLIDKRQRNRCQYC | 176 | P19793 | |
| RRNRCQYCRFQKCLA | 311 | P43354 | |
| RNRCQYCRFQKCLSV | 341 | Q92570 | |
| CRAAFCFRRCRDCLQ | 86 | Q8NAX2 | |
| DCTVDKRQRNRCQYC | 246 | P28702 | |
| WNSDCTRRCRCFRRN | 1441 | O75443 | |
| CIYCRRGNRYCRRVC | 266 | Q9H2S6 | |
| CEQCRRRVTKYFCSR | 321 | Q93098 | |
| QLDCLNRDNYIRSCR | 526 | Q04727 | |
| CRERTFGARCDRYCQ | 231 | Q96GP6 | |
| FGARCDRYCQCFRGR | 236 | Q96GP6 | |
| DFCFRQRRYLESARC | 431 | Q9P253 | |
| CLIDKRQRNRCQYCR | 181 | P48443 | |
| RQRNRCQYCRYQKCL | 186 | P48443 | |
| DAYCFRVQDVACRCR | 2296 | Q9NY15 | |
| EETRRFYACSACRDR | 56 | Q9H5U6 | |
| YWSLRTNNRRCCYRC | 5216 | O14686 |